Press Release ReCode Therapeutics Doses First Patient in Phase 1 Clinical Study of Novel mRNA-based Therapy for the Treatment of Primary Ciliary Dyskinesia 3 January 2024
Press Release Summit Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference 3 January 2024
Press Release Areteia Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 3 January 2024
Press Release SentinelOne® to Expand Cloud Security Capabilities with Acquisition of PingSafe 3 January 2024
Press Release LumiThera Provides Update on FDA Review of Valeda Treatment for Dry AMD Patients 3 January 2024
Press Release SkyWater Technology Announces Participation in 26th Annual Needham Growth Conference 3 January 2024
